Cargando…
Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272941/ https://www.ncbi.nlm.nih.gov/pubmed/37339924 http://dx.doi.org/10.1016/j.ejim.2023.06.014 |
| _version_ | 1785059608243470336 |
|---|---|
| author | Kawazoe, Mai Nishio, Junko Hirose, Wataru Furukawa, Karin Nanki, Toshihiro |
| author_facet | Kawazoe, Mai Nishio, Junko Hirose, Wataru Furukawa, Karin Nanki, Toshihiro |
| author_sort | Kawazoe, Mai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10272941 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | European Federation of Internal Medicine. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102729412023-06-16 Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases Kawazoe, Mai Nishio, Junko Hirose, Wataru Furukawa, Karin Nanki, Toshihiro Eur J Intern Med Article European Federation of Internal Medicine. Published by Elsevier B.V. 2023-06-16 /pmc/articles/PMC10272941/ /pubmed/37339924 http://dx.doi.org/10.1016/j.ejim.2023.06.014 Text en © 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Kawazoe, Mai Nishio, Junko Hirose, Wataru Furukawa, Karin Nanki, Toshihiro Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases |
| title | Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases |
| title_full | Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases |
| title_fullStr | Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases |
| title_full_unstemmed | Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases |
| title_short | Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases |
| title_sort | safety of sars-cov-2 mrna vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272941/ https://www.ncbi.nlm.nih.gov/pubmed/37339924 http://dx.doi.org/10.1016/j.ejim.2023.06.014 |
| work_keys_str_mv | AT kawazoemai safetyofsarscov2mrnavaccinesandeffectsofimmunosuppressivedrugsonadversereactionsinpatientswithrheumaticdiseases AT nishiojunko safetyofsarscov2mrnavaccinesandeffectsofimmunosuppressivedrugsonadversereactionsinpatientswithrheumaticdiseases AT hirosewataru safetyofsarscov2mrnavaccinesandeffectsofimmunosuppressivedrugsonadversereactionsinpatientswithrheumaticdiseases AT furukawakarin safetyofsarscov2mrnavaccinesandeffectsofimmunosuppressivedrugsonadversereactionsinpatientswithrheumaticdiseases AT nankitoshihiro safetyofsarscov2mrnavaccinesandeffectsofimmunosuppressivedrugsonadversereactionsinpatientswithrheumaticdiseases |